Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021

被引：11
|
作者：
Indenbaum, Victoria [1 ]
Lustig, Yaniv [1 ,2 ]
Mendelson, Ella [1 ,2 ]
Hershkovitz, Yael [3 ]
Glatman-Freedman, Aharona [2 ,3 ]
Keinan-Boker, Lital [3 ,4 ]
Bassal, Ravit [2 ,3 ]
机构：
[1] Minist Hlth, Cent Virol Lab, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel
[3] Sheba Med Ctr, Israel Ctr Dis Control, Minist Hlth, Ramat Gan, Israel
[4] Univ Haifa, Sch Publ Hlth, Haifa, Israel
来源：
EUROSURVEILLANCE | 2021年 / 26卷 / 48期
关键词：
SYNDROME CORONAVIRUS 2;
D O I：
10.2807/1560-7917.ES.2021.26.48.2101040
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 to than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.
引用
收藏
页数：5
相关论文
共 44 条
  • [21] Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021
    Barrett, Catherine E.
    Koyama, Alain K.
    Alvarez, Pablo
    Chow, Wilson
    Lundeen, Elizabeth A.
    Perrine, Cria G.
    Pavkov, Meda E.
    Rolka, Deborah B.
    Wiltz, Jennifer L.
    Bull-Otterson, Lara
    Gray, Simone
    Boehmer, Tegan K.
    Gundlapalli, Adi, V
    Siegel, David A.
    Kompaniyets, Lyudmyla
    Goodman, Alyson B.
    Mahon, Barbara E.
    Tauxe, Robert, V
    Remley, Karen
    Saydah, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (02): : 59 - 65
  • [22] Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study
    Li, Jing
    Ge, Menglei
    Dai, Shuzhi
    Song, Qinwei
    Liu, Weijie
    Wang, Ying
    Xu, Wenjian
    Ma, Lijuan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study
    Wurzel, Danielle
    McMinn, Alissa
    Hoq, Monsurul
    Blyth, Christopher C.
    Burgner, David
    Tosif, Shidan
    Buttery, Jim
    Carr, Jeremy
    Clark, Julia E.
    Cheng, Allen C.
    Dinsmore, Nicole
    Francis, Joshua Reginald
    Kynaston, Anne
    Lucas, Ryan
    Marshall, Helen
    McMullan, Brendan
    Singh-Grewal, Davinder
    Wood, Nicholas
    Macartney, Kristine
    Britton, Phil N.
    Crawford, Nigel W.
    BMJ OPEN, 2021, 11 (11):
  • [24] Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England (vol 6, pg 384, 2022)
    Mensah, A. A.
    Campbell, H.
    Stowe, S.
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (06): : E20 - E20
  • [25] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021
    Good, Mary K.
    Czarnik, Michaila
    Harmon, Kimberly G.
    Aukerman, Doug
    O'Neal, Catherine S.
    Day, Carly
    Goerl, Kyle
    Sifre, Katlynn
    Fink, Steven
    Riggs, Margaret A.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S236 - S242
  • [26] Epidemiology and clinical features of SARS-CoV-2 infection in hospitalized children across four waves in Hungary: A retrospective, comparative study from March 2020 to December 2021
    Takacs, Andrea T.
    Bukva, Matyas
    Gavaller, Gabriella
    Kapus, Katalin
    Rozsa, Maria
    Ban-Gagyi, Boglarka
    Sinko, Maria
    Szucs, Daniel
    Terhes, Gabriella
    Bereczki, Csaba
    HEALTH SCIENCE REPORTS, 2022, 5 (06)
  • [27] SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021
    Griffin, Jennifer B.
    Haddix, Meredith
    Danza, Phoebe
    Fisher, Rebecca
    Koo, Tae Hee
    Traub, Elizabeth
    Gounder, Prabhu
    Jarashow, Claire
    Balter, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (34): : 1170 - 1176
  • [28] SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
    Suntronwong, Nungruthai
    Vichaiwattana, Preeyaporn
    Klinfueng, Sirapa
    Puenpa, Jiratchaya
    Kanokudom, Sitthichai
    Assawakosri, Suvichada
    Chansaenroj, Jira
    Srimuan, Donchida
    Thatsanatorn, Thaksaporn
    Songtaisarana, Siriporn
    Sudhinaraset, Natthinee
    Wanlapakorn, Nasamon
    Poovorawan, Yong
    PLOS ONE, 2023, 18 (04):
  • [29] SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
    Danza, Phoebe
    Koo, Tae Hee
    Haddix, Meredith
    Fisher, Rebecca
    Traub, Elizabeth
    OYong, Kelsey
    Balter, Sharon
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (05): : 177 - 181
  • [30] Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey
    Ben David, Shirley Shapiro
    Gez, Sharon Baruch
    Adler, Limor
    Kovatch, Rada
    Rahamim-Cohen, Daniella
    Shamir-Stein, Na'ama
    Shahar, Arnon
    Mizrhi-Reuveni, Miri
    VACCINE, 2024, 42 (05) : 1154 - 1159
12345